SEGHI Study: Defining the Best Surveillance Strategy in Hodgkin Lymphoma after First-Line Treatment.
Bastos Oreiro M, Martín R, Gomez P, López Muñoz N, Rodriguez A, Liébana M, Navarro B, Sánchez-González B, Marí P, Pérez de Oteiza J, Gutiérrez A, Bento L, Domingo Doménech E, Vidal MJ, Del Campo R, Pérez Ceballos E, Infante M, Roldán A, García Belmonte D, Santero M, Sureda A, Sanz RG, On Behalf Of The Geltamo Group.
Bastos Oreiro M, et al. Among authors: gutierrez a.
Cancers (Basel). 2021 May 17;13(10):2412. doi: 10.3390/cancers13102412.
Cancers (Basel). 2021.
PMID: 34067616
Free PMC article.